Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials von Ruff, Christian T, Dr, Giugliano, Robert P, MD, Braunwald, Eugene, Prof, Hoffman, Elaine B, PhD, Deenadayalu, Naveen, MPH, Ezekowitz, Michael D, Prof, Camm, A John, Prof, Weitz, Jeffrey I, Prof, Lewis, Basil S, Prof, Parkhomenko, Alexander, Prof, Yamashita, Takeshi, Prof, Antman, Elliott M, Prof

Volltext

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial von Ruff, Christian T, Dr, Giugliano, Robert P, MD, Braunwald, Eugene, Prof, Morrow, David A, MD, Murphy, Sabina A, MPH, Kuder, Julia F, MA, Deenadayalu, Naveen, MPH, Jarolim, Petr, MD, Betcher, Joshua, PhD, Shi, Minggao, PhD, Brown, Karen, PhD, Patel, Indravadan, MD, Mercuri, Michele, MD, Antman, Elliott M, Prof

Volltext

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48 von Gupta, Deepak K, Shah, Amil M, Giugliano, Robert P, Ruff, Christian T, Antman, Elliott M, Grip, Laura T, Deenadayalu, Naveen, Hoffman, Elaine, Patel, Indravadan, Shi, Minggao, Mercuri, Michele, Mitrovic, Veselin, Braunwald, Eugene, Solomon, Scott D

Volltext

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial von Mega, Jessica L, Dr, Walker, Joseph R, PharmD, Ruff, Christian T, MD, Vandell, Alexander G, PhD, Nordio, Francesco, PhD, Deenadayalu, Naveen, MPH, Murphy, Sabina A, MPH, Lee, James, PhD, Mercuri, Michele F, MD, Giugliano, Robert P, MD, Antman, Elliott M, Prof, Braunwald, Eugene, Prof, Sabatine, Marc S, Dr Prof

Volltext

Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation von Ruff, Christian T., MD, MPH, Giugliano, Robert P., MD, SM, Braunwald, Eugene, MD, Mercuri, Michele, MD, PhD, Curt, Valentin, MD, Betcher, Joshua, PhD, Grip, Laura, AB, Cange, Abby L., BS, Crompton, Andrea E., BS, Murphy, Sabina A., MPH, Deenadayalu, Naveen, MPH, Antman, Elliott M., MD

Volltext

Vorapaxar in the Secondary Prevention of Atherothrombotic Events von Morrow, David A, Braunwald, Eugene, Bonaca, Marc P, Ameriso, Sebastian F, Dalby, Anthony J, Fish, Mary Polly, Fox, Keith A.A, Lipka, Leslie J, Liu, Xuan, Nicolau, José Carlos, Ophuis, A.J. Oude, Paolasso, Ernesto, Scirica, Benjamin M, Spinar, Jindrich, Theroux, Pierre, Wiviott, Stephen D, Strony, John, Murphy, Sabina A

Volltext

Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial von Cavallari, Ilaria, Ruff, Christian T., Nordio, Francesco, Deenadayalu, Naveen, Shi, Minggao, Lanz, Hans, Rutman, Howard, Mercuri, Michele F., Antman, Elliott M., Braunwald, Eugene, Giugliano, Robert P.

Volltext

Transition of Patients From Blinded Study Drug to Open-Label Anticoagulation: The ENGAGE AF-TIMI 48 Trial von RUFF, Christian T, GIUGLIANO, Robert P, DEENADAYALU, Naveen, ANTMAN, Elliott M, BRAUNWALD, Eugene, MERCURI, Michele, CURT, Valentin, BETCHER, Joshua, GRIP, Laura, CANGE, Abby L, CROMPTON, Andrea E, MURPHY, Sabina A

Volltext

PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL von Douketis, James, Weitz, Jeffrey, Murphy, Sabina, Deenadayalu, Naveen, Crompton, Andrea Elizabeth, Mercuri, Michele, Ruff, Christian, Antman, Elliott, Giugliano, Robert

Volltext

Prognostic Implications of Low Level Cardiac Troponin Elevation Using High‐Sensitivity Cardiac Troponin T von Grinstein, Jonathan, Bonaca, Marc P., Jarolim, Petr, Conrad, Michael J., Bohula‐May, Erin, Deenadayalu, Naveen, Braunwald, Eugene, Giugliano, Robert P., Newby, L. Kristin, Sabatine, Marc S., Morrow, David A.

Volltext

Abstract 17121: Reduction in Total Cardiovascular Events With Long-term Use of Ticagrelor in Patients With Prior Myocardial Infarction in the PEGASUS-TIMI 54 Trial von Murphy, Sabina A, Bonaca, Marc P, Goto, Shinya, Bhatt, Deepak L, Steg, Philippe Gabriel, Storey, Robert F, Deenadayalu, Naveen, Kuder, Julia F, Magnani, Giulia, Theroux, Pierre, Nicolau, José C, López-Sendón, Jose, Dalby, Anthony J, Goudev, Assen, Ardissino, Diego, Corbalan, Ramon, Jensen, Eva C, Held, Peter, Braunwald, Eugene, Sabatine, Marc S

Volltext

RELATIONSHIP BETWEEN DOSE, ANTI-FACTOR XA ACTIVITY, AND OUTCOMES IN PATIENTS RANDOMIZED TO EDOXABAN IN THE ENGAGE AF-TIMI 48 TRIAL von Ruff, Christian T, Giugliano, Robert, Braunwald, Eugene, Morrow, David, Murphy, Sabina, Deenadayalu, Naveen, Jarolim, Petr, Betcher, Joshua, Shi, Minggao, Brown, Karen S, Patel, Indravadan, Mercuri, Michele, Antman, Elliott

Volltext

Cerebrovascular Events in 21105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrilla... von GIUGLIANO, Robert P, RUFF, Christian T, DUGGAL, Anil, DAVE, Jay, MINGGAO SHI, MERCURI, Michele, ANTMAN, Elliott M, BRAUNWALD, Eugene, ROST, Natalia S, SILVERMAN, Scott, WIVIOTT, Stephen D, LOWE, Cheryl, DEENADAYALU, Naveen, MURPHY, Sabina A, GRIP, Laura T, BETCHER, Joshua M

Volltext

CARDIAC STRUCTURE AND FUNCTION AND CHADS2 RISK SCORE IN PATIENTS WITH ATRIAL FIBRILLATION: THE EFFECTS ANTICOAGULATION WITH FACTOR XA NEXT GENERATION IN AFTHROMBOLYSIS IN MYOCARDIA... von Gupta, Deepak K, Shah, Amil, Giugliano, Robert, Ruff, Christian, Antman, Elliott, Grip, Laura T, Deenadayalu, Naveen, Hoffman, Elaine, Betcher, Joshua, Patel, Indravadan, Shi, Minggao, Braunwald, Eugene, Solomon, Scott

Volltext